About doDOC
doDOC is a Healthcare company based in Boston (United States) founded in 2014, and was acquired by Envision Pharma Group in March 2021. Web-based audit and compliance software for pharma companies is provided. doDOC has raised $320 thousand across 4 funding rounds from investors including Envision Pharma Group, Techstars and BGI. doDOC offers products and services including iEnvision, doDOC, and Datavision. Its focus areas include HealthTech, Life Sciences Tech, GRC Solutions and Medical Writing. Its competitors include Author-it Software, Yseop and Standard Analytics; 3 of its 3 listed competitors have raised funding.
Company details
doDOC was founded in 2014 in Boston, United States, and operates in the pharmaceutical sector. Audit and regulatory documents are streamlined through web-based tools that allow importation, peer collaboration, citation addition, and one-click formatting. Features include audit trails, granular access controls, workflow management, automatic document structuring, and data auto-formatting compliant with FDA and EMA regulations.
- Headquarters Boston, United States
- Stage Acquired
- SectorsHealthcare
- Website dodoc.com
- Social LinkedIn X Facebook
- Acquired by Envision Pharma Group (Mar 2021)
- Total Equity Funding$320K (USD)
in 4 rounds
- Latest Funding Round$200K (USD), Seed
Sep 2015
- InvestorsEnvision Pharma Group
& 3 more
- Acquired byEnvision Pharma Group
(Mar 2021)
Products & Services of doDOC
doDOC offers a comprehensive portfolio of products and services, including iEnvision, doDOC, and Datavision.
Web-based tool for managing evidence and grants in pharmaceuticals
Platform for real-time editing and reviewing of scientific documents
Software for planning and reporting scientific publications efficiently
Funding Insights of doDOC
doDOC has successfully raised a total of $320K across 4 strategic funding rounds. The most recent funding activity was a Seed round of $200 thousand completed in September 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $320,000
- Total Rounds 4
- Last Round Seed — $200,000
- First Round $122,000
(Dec 2014)
- Investors Count 3
All 4 funding rounds of doDOC with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2015 | $200,000 | Seed | – | Caixa Capital | – |
| Jun 2015 | $120,000 | Seed | – | Techstars | – |
| Dec 2014 | Seed | – | BGI | – | |
| Dec 2014 | $122,000 | Grant | – | – | – |
4 investors in total: 4 institutional.
Investors in doDOC
doDOC has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Envision Pharma Group, Techstars and BGI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and Venture capital firm | caixacapital.pt | Lisbon, Portugal | ||
Startups are accelerated globally without sector restrictions through structured programs. | 2006 | techstars.com | New York, United States | |
BGI is recognized as a startup accelerator focused on sustainability. | 2010 | bgi.pt | Lisbon, Portugal | |
Compliant global publication planning is offered for life sciences. | 2001 | envisionpharmagroup.com | Fairfield, United States |
Investor details for doDOC
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of doDOC
9 people are tracked at doDOC (3 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Sofia Alves | Head of Standards & Quality | Leadership |
João Miguel Barbosa | Head of Customer Success | Leadership |
Leandro Braguês | Chief Technology Officer / Chief Security Officer | Leadership |
Filipe Assunção | Software Engineer | Team |
Mário Rui Castro | Product Owner | Team |
Pedro Castro | Software Quality Assurance Tester | Team |
Pedro Figueiredo | Software Developer | Team |
Hugo David | Web Engineer | Team |
João Mendes | Full Stack Engineer | Team |
Complete people profiles for doDOC
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of doDOC
4 dated milestones of doDOC across 7 years, from founding to its latest funding, stage changes and deals.
- Founded doDOC is founded.
- Funding First funding round of $122K.
- Funding Latest funding round, Seed, of $200K.
- Exit Acquired by Envision Pharma Group.
Competitors of doDOC
doDOC has 3 listed competitors in our database, 3 of them funded. They include Author-it Software, Yseop and Standard Analytics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| author-it.com | 1996 | Seattle, United States | $9.39M | Enterprise authoring, content management & publishing platforms | ||
| yseop.com | 2008 | New York, United States | $9.3M | Automated natural language generation software for regulatory writing is provided. | ||
| standardanalytics.io | 2014 | New York, United States | $1.28M | Scientific publishing software |
Detailed competitors of doDOC
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as doDOC (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dodoc
Complete news archive for doDOC
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about doDOC
doDOC was founded in 2014.
doDOC is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
doDOC is a funded company, having raised a total of $320K across 4 funding rounds to date.
doDOC was founded in 2014 in Boston, United States, and operates in the pharmaceutical sector. Audit and regulatory documents are streamlined through web-based tools that allow importation, peer collaboration, citation addition, and one-click formatting. Features include audit trails, granular access controls, workflow management, automatic document structuring, and data auto-formatting compliant with FDA and EMA regulations.
doDOC's top competitors include Yseop, Author-it Software and Standard Analytics.
doDOC offers iEnvision, doDOC, and Datavision.
doDOC has 4 investors. Key investors include Envision Pharma Group, Techstars, BGI, and Caixa Capital.
Yes. doDOC was acquired by Envision Pharma Group in March 2021.